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Objective: By definition a rare disease affects fewer than 1 in 2,000 people but
collectively 1 in 17 people are affected at some time in their lives. Rare disease patients
often describe feeling isolated and unsupported. The needs of individuals living with
rare disease(s) are not well met globally and have not been specifically explored in
Northern Ireland.
Methods: An online survey was conducted in spring of 2017, focused on information
and communication needs, to identify overarching themes. Databases were searched to
place responses in an international context.
Results: There were 240 survey respondents with four overarching themes identified:
sources of information; medical care; rare disease community; and public awareness.
Thirty relevant papers resulted from the literature search. A coordinated and transparent
approach for improved medical care is needed where researchers, practitioners, and
policy makers work with patients, carers, and rare disease advocates to ensure a
fully considered rare disease strategy is implemented. In line with that developed by
many other countries, a physical or virtual Northern Ireland reference network or center
of excellence for rare diseases would provide an important strategic link. Sustainable
funding, resources for rare disease charities, and more cross-border working would help
build a local rare disease community. Major challenges highlighted include finding the
right health and social care information. The internet was the most regularly accessed,
and perceived as the easiest way, to source information on rare disease. Improved
signposting to accredited information, ideally by the creation of a locally relevant online
information hub, a local rare disease registry that can integrate with international systems,
a local rare disease coordinator, and improving public awareness are urgent needs.
Conclusions: Aligned to internationally reported outcomes, practical issues for future
development based on the voices of individuals living, and working with a rare condition
are described. It is essential that ongoing research evaluates changes to ensure that the
best possible structures and mechanisms are put in place to improve communication
and information systems for those affected by a rare condition(s).
Keywords: rare disease, communication, information systems, patients, healthcare, public awareness
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INTRODUCTION
A rare disease is defined as occurring in <1 in 2,000 people (1)
and is often associated with major unmet health needs (2). There
are more than 8,000 rare diseases identified and cumulatively rare
diseases are common, representing a significant public health
concern. One in 17 people in the United Kingdom (UK) being
affected at some time in their lives (3). Problems encountered
because of the low incidence of individual rare diseases include
lack of accurate diagnosis, lack of clarity about which specialist
referrals are required post-diagnosis, lack of coordinated clinical
approach, insufficient social support, and medical professionals
who have not heard of a disease but are treating affected patients
(3). This makes it difficult to optimize treatment strategies that
effectively manage the rare disease, and to know what treatment
options are most appropriate across specialities. Therefore,
improving communicationmechanisms both within, and around
the healthcare system is of vital importance to individuals living
and working with rare diseases.
In 2009 the European Council recommended that member
states should have in place a plan or strategy for rare disease
to integrate local, regional, and national developments in this
field (2009/C 151/02). This prompted a UK-wide consultation
toward a UK Strategy for Rare Disease, which was published in
2013 with approval from Health Ministers in Scotland, Wales,
England, and Northern Ireland (3). A Northern Ireland Rare
Disease Stakeholder Forum (including representatives from the
Department of Health and Social Services, Health and Social Care
Board, Public Health Agency, clinicians, service users, advocacy
groups, and researchers) developed a statement of intent for Rare
Diseases in Northern Ireland (2014), leading to the publication
of the first Northern Ireland Rare Diseases Implementation Plan
(4). This Northern Ireland Rare Disease Implementation Plan
was informed by the stakeholder forum and aligned to the
Northern Ireland Executive’s Programme for Government and
“Transforming Your Care” policy which described a new model
for the delivery of integrated health and social care services in
Northern Ireland. Northern Ireland does not have a center of
expertise for rare disease, is not a European reference network,
does not have a rare disease coordinator, does not have a rare
disease national/regional office, and does not have a national rare
disease registry. A not-for-profit charity was established in 2012
to help connect, educate, innovate, and advocate for individuals
living, and working with rare disease(s)—The Northern Ireland
Rare Disease Partnership (www.nirdp.org.uk). The Northern
Ireland Rare Disease Implementation Plan incorporates six
key themes describing 51 commitments, (1) empowering those
affected by rare disease, (2) identifying and preventing rare
disease, (3) diagnosis and early intervention, (4) coordination of
care, (5) the role of research, and (6) cross-border collaboration
with the Republic of Ireland. The research presented in this
manuscript will inform all themes in this Northern Ireland Plan.
Abbreviations: ERNs, European Reference Networks; GP, General Practitioner;
NHS, National Health Service; UK, United Kingdom; USA, United States of
America.
The aim of this research is to evaluate the perceived availability
of resources and communication preferences across Northern
Ireland, and to place these findings in the wider international
context by conducting a comprehensive literature review.
METHODS
Survey
A survey was developed in collaboration with the Northern
Ireland Rare Disease Partnership (NIRDP), which is a central
organization in Northern Ireland aiming to advocate, connect,
educate and innovate for individuals living and working with
rare diseases across Northern Ireland. NIRDP is a not-for-
profit partnership of individuals living and working with rare
diseases in Northern Ireland including researchers, clinicians,
allied health professionals, patients, carers, voluntary groups,
rare disease charities, and industry partners. This survey
aimed to evaluate communication for rare diseases within the
healthcare system, how individuals’ access or engage withmedical
practitioners, and how individuals generally access information
about rare diseases. The target audience was any individual
living and/or working with a rare disease in Northern Ireland
and there is ethical approval from research ethics committee,
Northern Ireland. Demographic information was collected and
stored separately using the following questions:
a) Do you currently live in Northern Ireland?
b) What is your gender?
c) Which age bracket best describes you?
d) Which group best describes your ethnic background
or association?
Also included were questions to help prioritize improvement
within, and allied with, communication and information
processes of the integrated health, and social care system in
Northern Ireland.
The online survey was promoted by the NIRDP via their
social media accounts on Twitter (@NI_RDP; 1,090 followers)
and Facebook (@NIRDPNews; 858 members) from January-June
2017 and further disseminated by individuals, member charities,
and voluntary groups; there was not a mechanism available to
track the reach of this dissemination through social media. The
survey was also described on the NIRDP website with a lay
summary (https://www.nirdp.org.uk/) and at four public rare
disease meetings geographically spread across Northern Ireland
in March and April 2017, where there was also the opportunity
to complete the survey in hard copy. Informed consent was
obtained from all participants. Consent was explicitly given by
each participant by actively ticking a “consent box” before they
could proceed with the survey. Anonymized responses were
collated in a spreadsheet and appropriately summarized in tables
and charts; respondents had the option to skip questions without
answering. Questions were of various formats including tick-box,
ranked and open text narrative responses (seeOnline Resource 1
for wording). There was the option to comment after all but one
of the questions and these comments were considered as part
of the results. Seven questions related to existing information,
two to improving information, and communication services
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FIGURE 1 | Flow chart illustrating literature review process where 30 full text articles were included in the final analysis. Papers were excluded after review of abstracts
as they were: not focused on rare disease; not to do with the topic of communication; about medical issues directly rather than the communication around them; not
in English; published prior to 2012; to do with animals rather than humans; not relevant to person to person communication (genetic communication for example);
about research practice rather than how to access research; related to achieving diagnosis rather than what is communicated around it; about symptoms which make
communication difficult rather than communication about the rare disease.
in the future, and one question asked for a general response
to the overall theme. Data retrieved from the information
and communication survey were analyzed both quantitatively
and thematically.
Literature Review
A comprehensive review of literature published since 2012
and written in English was conducted. Resources MEDLINE
on Ovid, Web of Science, and PubMed were searched using
search terms “communication” AND “rare disease,” with and
without including “Northern Ireland” (last updated 11th January
2018). Papers were initially screened by title with duplicates
removed, and then screened by abstract. The remaining articles
were screened by reading the full text and all those apparently
relating to communication in people living and working with
rare disease were included; no specific type of study or study
population was excluded at this stage. Papers were excluded after
review of abstracts if they were: not focused on rare disease; not
to do with the topic of communication; about medical issues
directly rather than the communication around them; not in
English; published prior to 2012; to do with animals rather
than humans; not relevant to person to person communication
(genetic communication for example); about research practice
rather than how to access research; related to achieving diagnosis
rather than what is communicated around it; about symptoms
whichmake communication difficult rather than communication
about the rare disease (Figure 1). For those articles included in
the review, the following data were extracted: year of publication,
country of study, and main findings (seeOnline Resource 2).
RESULTS
Survey Participants
240 participants completed the survey, with 38% (91/240)
completing the survey in full. Thirty one percent (75/240)
respondents identified themselves as a patient living with a
rare disease, 19% (45/240) as family of a person with a rare
disease, 18% (44/240) as carers and 14% (33/240) as healthcare
professionals. Others who completed the survey identified as
medical doctors, social support practitioners, managers, policy
makers, researchers, volunteers for rare disease charities, and staff
working in the charity sector. Interestingly, 22 people identified
as both carers and family members, indicating that people were
reporting with experience of multiple roles. There were 29%male
and 71% female respondents who described a gender, plus 6
respondents who did not specify. The majority of respondents
(87%) were over the age of 35 years, with 93% identifying as
British or Irish ethnicity (Figure 2).
Survey Responses for Information and
Communication
This survey resulted in a breadth of highly emotive responses
(Figure 3). The internet was the most regularly accessed source
of information for rare diseases (65% accessed it regularly)
followed by charity/support groups (48%). Results illustrating
how regularly information sources were accessed are summarized
in Figure 4. Orphanet, conferences, and information events
focused on rare disease were the three sources of rare disease
information where respondents most wished to know more.
Respondents reported varying levels of ease accessing diverse
information sources with only 78 individuals completing this
question in detail (Figure 4). Fifty eight percent of respondents
found the internet very easy to access and 32% manageable as an
accessible source of information, followed by social media with
38% stating it was very easy, and 21% manageable for access.
While access was relatively easy and 97% of respondents found
the internet useful, respondents noted that they often did not
know what was reliable when they were reading it online. Half of
respondents struggled to access information on conferences with
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FIGURE 2 | Sociodemographic information from respondents.
FIGURE 3 | Quotes from participants in the information and communication survey demonstrating the voice of the rare disease community in Northern Ireland.
more respondents finding it harder to access information from
medical professionals (32%) than from medical literature (27%).
The preferred top-ranked mechanism by which respondents
would wish to obtain clinical or research information in the
future was via a Northern Ireland information hub (website)
dedicated to rare diseases (Figure 5). A single individual or
organization coordinating information sources, and from a
charity or support group were second, and third ranked
respectively. Several respondents commented they were keen
to have access to a Center of Excellence (locally or overseas),
or international resource to obtain informed advice from
experts, while others would prefer a multidisciplinary hub
connecting hospital professionals directly with primary care
physicians and community medical professionals. One hundred
and eight individuals stated a preference for receiving face to face
information and support via disease specific charity events, with
tailored advice also available online, and in hard copy.
Two responses for the quality and quantity of information
were very positive commenting, “I have all the information
that I need in relation to managing. . . ” and “the NHS website
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FIGURE 4 | Regularity and ease of access of information sources for rare disease.
FIGURE 5 | Summary of how individuals prefer to access clinical and research information.
provides useful templates about disease specific information,”
however this was unusual. Most respondents described wanting
more information regarding diagnosis, prognosis, individual
care plans, relevant clinical trials/therapies, counseling, clinical
psychological support, improving lifestyle, and day to day living.
More than ¼ of respondents wanted more information at
diagnosis, while 30% of respondents were seeking more clinical
information on treatments. The majority of patients wanted
access to their own medical records as they are the coordinators
of their often-complex care needs.
In terms of non-clinical support, peer support was the
most commonly accessed (61%), with financial support
(49%), educational support (40%), and family support (39%)
also being frequently used. One respondent described their
diagnosis as, “a life-changing event.” Non-clinical psychological
support/counseling had the most responses of being unable
to find information regarding it (11%; 28% never tried to
access), relative to other non-clinical support options. Several
respondents commented they advocate and or coordinate their
own social care support.
Survey Responses for Engagement and
Priorities for Change
Several suggestions were described to promote good
engagement with individuals and/or teams involved with
rare diseases, including:
 A rare disease coordinator, although views varied on the role of
such a coordinator. Some individuals asked for a coordinator
whose role is to provide access to a variety of services using a
joined up multi-disciplinary approach, while others requested
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a coordinator with a more managerial role signposting to
relevant information and resources.
 “Good communication skills with the family and carers to
enable a degree of advanced planning when looking at a disease
trajectory or specific symptom led need.”
 Improved medical resources with a “joined up” approach
to rare diseases, more support, more specialist clinical staff,
regional clinics, more GP education on rare diseases, more
local information sessions for professionals.
 Reference network(s) enabling peer support (patients, family
members, carers, healthcare professionals) to connect.
 Working in an effective partnership with a coordinated
approach. “Accessibility . . .& mutual respect. . . combined with
openness and willingness to listen. . . reach consensus agreement
on actions to be taken. . . and act.”
 Clear communication with good information and signposting.
More public meetings, rare disease community consultations,
and social media engagement.
Barriers to engagement centered around poor communication,
insufficient resources, lack of transparency, lack of respect for the
patient voice, lack of local rare disease registry/poor identification
of individuals with a rare disease, lack of awareness, and
understanding, geographical separation/physical inaccessible,
and not knowing where or how to access support, services, and
information. Survey respondents indicated a serious problem
for a person with a rare disease is that health and social
care professionals don’t listen with respondents wanting more
“involvement of patients as experts,” “empathy,” and “a more
open mind from consultants when we present information we
have found.”
A range of priorities were suggested to improve information
sharing and communication for rare disease(s) in Northern
Ireland with the most commonly mentioned being:
 More public awareness (including through wider media
presence and public health campaigns).
 Sustainable funding for regular support meetings, resources
for rare disease charities/voluntary groups.
 More cross-border working to help build a local rare disease
community similar to that which exists for persons living
with cancer.
 Improved signposting to accredited existing information or
the creation of new relevant information, ideally by the
creation of a locally relevant online information hub.
 Development of a local rare disease registry that can integrate
with international systems.
 A local rare disease coordinator.
One hundred percent of respondents were unable to satisfactorily
obtain relevant information they were seeking about living
with a rare disease(s) in Northern Ireland. Respondents
highlighted needing more information that is easily accessible,
particular for:
 More information for healthcare professionals that is easily
accessible. GP surgeries in particular were specifically
highlighted as needing more information to better manage
rare disease patients.
 Information about sources of expertise—contact details for
experts and services with mechanisms to access.
 Individual disease information from diagnosis to disease
progression and treatment outcomes; links to best
practice guidelines.
Overall, responses encompassed four overarching themes,
illustrated in Figure 6 of priorities for change from individuals
living and working with rare disease in Northern Ireland:
improving medical care; signposting to reliable sources of
information; building a rare disease community; and public
awareness for rare disease(s).
Literature Review
The literature search returned 308 papers resulting in the
inclusion of 30 full text (Figure 1). With the addition of
“Northern Ireland” in the search terms (i.e., “rare disease”[All
Fields] AND “communication”[All Fields] AND “Northern
Ireland”[All Fields]), no results were returned. Included articles
were from Europe (the continent, Denmark, France, Germany,
Italy, Malta, England, Spain, Sweden, and UK), Australia, and
the United States of America (USA) (see Online Resource 2).
Results from the survey aligned to internationally reporting
outcomes from this literature review. This literature was
categorized using the four themes, although themes 2 and 3,
sources of information and rare disease community, overlapped
considerably in the literature review results and so are included
as a joint theme below.
DISCUSSION
Context of Research
Communication can be especially challenging for those
diagnosed with a rare condition with isolation described as an
immediate consequence (5). Questions faced by many who are
affected by a rare disease include: Due to the condition being
rare, who can empathize with persons living or working with the
condition? Who will be able to offer suggestions or experience?
And who will have accurate or reputable information?
In a heavily technology dependent society, the internet now
provides access to information in a way unimaginable 50 years
ago. Therefore, it is necessary to take account of technology
solutions for accessing rare disease information and improving
communication mechanisms around rare disease. Isolation is a
consistently reported theme (6) and the internet offers a practical
solution in rural areas. However, even in Northern Ireland,
approximately 56,000 premises do not have access to broadband
internet and therefore cannot easily browse the web, access
email, or use video services (7). Ofcom (7) reported that <1%
of urban properties cannot get decent broadband compared to
23% of rural properties in Northern Ireland. Mazzucato et al. (8)
demonstrated that the existence of a telephone helpline is one of
the greatest measures of success in regards the evaluation of a
national strategy around rare disease. Communication methods
for persons living and working with a rare condition do need
to be considered carefully to ensure equity of access to good
communication and information tools.
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FIGURE 6 | Priorities from thematic analysis of the information and communication survey results.
Communication around rare disease is a challenge for
researchers and healthcare professionals. Progress in the
understanding of inherited rare diseases is often derived
from international genetic research, in separate institutions
globally and stored in differing formats. Local consolidated rare
disease research infrastructures would facilitate effective global
communication for rare diseases. International collaborations
like IRDiRC (9) have made significant strides understanding rare
disease mechanisms, but it is challenging for many countries to
join such endeavors.
Theme 1: Medical Care
Health and Social Care Professionals
Survey respondents revealed serious concerns about health and
social care professionals not listening to patients or carers.
Anonymous (10) states problems for parents speaking to
geneticists include, being patronized, their research not being
taken seriously, and a lack of empathy. Medical professionals do
not ordinarily get the opportunity to explore how someone with
a rare disease copes with day-to-day life yet Jeppeson et al. (11)
state this valuable insight would allow for deeper understanding
and more sympathetic communication. Greulich et al. (12)
highlighted the lack of knowledge of general practitioners and
suggest a web-based module might increase their knowledge
of the specific disease and improve patient care. Budych et al.
(13) have shown improved outcomes result from care providers
recognizing and acknowledging patient’s expertise, and be willing
to partner with them in the decision making around treatment.
Our findings reported the internet as the most regularly
accessed and perceived as the easiest approach to source
information on rare disease. While some individuals regularly
attend international conferences and trawl professional
information sources to identify the latest research and treatment
options for their rare disease(s), many people living with a rare
disease describe accessing information via a general search of
the internet as they find it considerably harder to access medical
professionals, local and international information events and
conferences, and the medical literature. This leaves the question
of what affect does this have on the engagement between patient
and medical professionals, and the patients’ well-being who is
relying on sourcing information themselves with no obvious
credibility or reliability?
Diagnosis
A significant proportion of individuals found information
around diagnosis and prognosis challenging. Better signposting
to existing accredited health and social care information or
the creation of relevant required information is needed. Post-
diagnosis, information is also needed as a diagnosed patient may
receive little or no information on what the short, medium,
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and long-term steps within the healthcare system are. Although
a small study, Capioppo et al. (14) showed that parents’
expectations on seeking diagnosis and information about their
child’s condition can be broken down into five categories;
predictability, management of the condition, family planning,
finding answers, and helping science.
Multidisciplinary Approach
The multidisciplinary approach can be challenging, as
highlighted in a USA survey by McClain et al. (15) which
evaluated communication systems for healthcare professionals
dealing with rare disease. Berlage et al. (16), in the case of
a patient with obstetric issues, illustrated how necessary or
missed steps in a system could be identified, thus supporting the
multidisciplinary approach. Further technology allows various
healthcare professionals to collaborate to improve the welfare
and care of patients (17).
A strategy of specified (co-located) appointments for rare
disease patients post-diagnosis would facilitate more forward
planning and cohesion between the specialities and aid a
multidisciplinary approach. Although not directly addressed
in any one question, many respondents commented that
communication between services in the UK National Health
Service (NHS) does not typically happen successfully for
rare disease patients. For example, a respondent would like
access to a “care plan co-produced by a multidisciplinary team
with the patient/carer at the centre” and “A co-ordinated and
transparent approach at a Departmental level working with
patients/carers/advocates to ensure a fully considered strategy is
developed and implemented”; and another “There is complete
unorganisation within the health service. No one wants to accept
responsibility and information gets lost. . . They need to take a step
back, sing from the same hymn sheet and realize that the person on
the other end of the phone is going through life shattering changes.”
In Europe established centers of expertise can specialize in
one or a number of rare diseases, they include patients and
their function is evaluated. As Taruscio et al. (18) state, it
“gathers or coordinates . . . multidisciplinary competences/skills,
including paramedical skills and social services, in order to
serve the specific medical, rehabilitative, palliative and social
needs of RD (rare disease) patients. . . Centres of excellence
should offer a wide range of specialized services: consultations,
medical examinations, using specialized equipment, genetic testing,
counseling and social care.” Our survey indicates that this kind
of accessible, all-in-one, source of information and support is an
important goal for patients with a rare disease. Ideally Northern
Ireland should develop a reference network hub as a unique
access point to national and international centers of excellence,
additionally acting as a communication network point between
medical professionals.
Cross-Border Collaboration
Collaboration in the healthcare approach to rare disease of
Northern Ireland and the Republic of Ireland has been identified
as important (4). Although there can be challenges due to the
different states involved, the current 24 European Reference
Networks (ERNs) that have been established demonstrate that
these challenges can be overcome (19). There is great capacity
for cross-border collaboration and some legalization is already in
place whereby, facilitated by ERNs, patients can access healthcare
from other countries in the EU if they cannot get access to the
care they need in their own country (20).
An example of effective cross-border care is between Malta
and the UK, where Salbia et al. (21) identified four key
components as supportive of the collaboration: “longevity and
personal relationships” where medical professionals developed
relationships to facilitate ease of the process; “communication
and data sharing” facilitated by the UK receiving detailed patient
summaries, results from investigations, and actions taken; a
“shared care approach” where the UK teams treat the Maltese
patients equitably, and accurate and timely information is sent
back to the Maltese so that they can provide continuity of care
for the patient; and “well-established support systems” such as
transport to and from the hospital, accommodation for carers,
and a contact for such issues (22).
International expert multidisciplinary clinics require capacity
for their expertise to be shared with local healthcare providers,
who may have patients with mobility limitations that cannot
attend a centralized center. Work by Moreo et al. (22) on rare
pulmonary diseases highlighted mobility limitations and that
often family are heavily involved in the patients care, as in the
cases of rare disease. They recommended providing training and
education to the patient and their caregiver to aid with managing
medication and to share the plan for care when transitioning
between care services.
Theme 2 and 3: Sources of Information and
Rare Disease Community
Two responses suggested they had sufficient information, but this
was a minority view, which raises the question, are some rare
diseases better dealt with in the NHS than other rare diseases? Or
is it the case that some healthcare providers are more proficient
or successful in accessing this information on behalf of their
patients, or at least pointing them in the right direction?
Support Groups
Half of our respondents accessed charity/support groups
regularly; with charity support groups the second most regularly
accessed source of information after the internet. Pauer et al.
(23) affirms our findings that support groups provide invaluable
information to those who are affected by rare disease. However,
specialist support groups exist for only a minority of rare disease
diagnoses. Further they found information such as genetic
counseling to be lacking, similar to comments in our survey.
Ultimately there is insufficient good quality assured information
available and improvements around sources of information for
those affected by rare disease is needed.
Doyle (24) highlights support groups are particularly
important during the “transition” phase from childhood to
adulthood were different age groups have different reflections on
the interactions between themselves and others with their disease.
Having support from the rare disease communities is invaluable,
however having support from peers who are of a similar age and
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have beenmoving through the healthcare system at the same time
as a patient is also important.
The issue of public stigma emerged from some responses to
our survey. Zhu et al. (25) highlighted that groups of patients who
are affected by the same disease empower one another to not be
embarrassed by what is happening to them, and in such a way that
they have confidence to advocate on behalf of others with their
condition. Again highlighting the importance of support groups.
As Vicari and Cappai (26) found in exploring how
connections are made via online methods, patient organization
websites were more likely to connect people from their website
to community formed pages (where groups of people affected by
rare disease are communicating and sharing their own personally
gained knowledge and experience), than they were to have people
connect to other specific rare disease websites. Rocha et al.
(27) reported patients increasingly using social media to seek
information about diagnosis, peer support, and to read posts
from rare disease organizations.
Psychological Support and Counseling
Challenges around accessing the right healthcare information
and support were highlighted by our survey and Anderson et al.
(28) who conducted a survey among the parents of children
who had been diagnosed with a rare condition and referred to a
specialist center. Similar to our own findings, and a very common
theme, each family had varying experiences, some with very
bad experiences in receiving diagnosis, often not being offered
counseling, but others who received very good care from their
general practitioners’ who were very empathetic. The families
reported a desire to access to their healthcare records, to make
transitioning through their healthcare system much easier, and
they valued support networks and wanted more information
about social and psychological support.
Medical Records/Treatment
Providing easily accessible information on drug/treatment
trials for rare diseases would be helpful for patients and
healthcare professionals. Several rare disease drugs have been
funded in Northern Ireland under managed access agreements;
respondents are keen to know more about the process of
obtaining orphan drugs. Stanarevic´ Katavic´ (29) conducted
semi-structured interviews with 15 respondents having one of
three rare diseases, confirming that common challenges rare
disease patients face include inaccessible new knowledge and
lack of information about drugs and insufficient support from
healthcare professionals.
Rare disease patients often see multiple healthcare
professionals who may be based in different geographical
locations and use different electronic systems. That creates
challenges when a consultant is not aware of interactions with
a patient and another medical professional; providing patients
access to their ownmedical records such as tests, medical history,
and communications from medical professionals would help
them coordinate their rare disease care across medical specialties.
Such resources exist for common conditions such as diabetes (30)
or using tools such as PatientView (31). Ultimately the inclusion
of a healthcare practitioner in the receipt of genetic information
would be ideal, and the opportunity for the recipient to be able
to get further tests and have access to reliable information is
crucial (32).
Registries
From the respondents of the survey a desire for a rare disease
registry was noted. Kourime et al. (33) state that key aspects
in the design of registries are that they are patient based, have
a sustainability strategy in place, have a group of people who
manage the registry, that the information can be shared within
the legal framework in place, and that it has sustainable funding.
Recruitment of individuals to sign-up to a rare disease registry
online was explored by Johnston et al. (34) who found that
social media as the most effective, and cost-effective method
of recruiting individuals, although there were demographic
implications to this approach, such as a higher representation of
women. Nevertheless they show that using social media platforms
is a highly effective way of recruiting participants to an online
registry and their methods could be replicable.
There are various types of rare disease registry in Europe:
public health, clinical, genetic research and treatment registries
(35), with differing methods of operating, and differing
objectives. In order to make it possible for these registries to
inter-work, homogeneity would need to be achieved in coding
and diagnosis systems. Registries across Europe would be in favor
of a portal through which the registries could all be accessed.
However, they would also hope to gain from this other forms of
support such as help with information technology, and shared
resources (36).
Patient Advocacy Groups
Blay et al. (37) report patient advocacy groups are more open
to information about current research questions and treatment
strategies than the doctors. This compounds the problem of
multidisciplinary working where even a reference network for
rare cancers is not finding medical professionals to be willing
participants in the progress and journey with the research
community working on rare disease. Patient advocacy groups
have also been found to be considerably useful when setting up
a research network as they have direct communication with the
people with a rare disease, and thus can more efficiently recruit
people to a study, but should be utilized more frequently at the
design stage of a study (38).
Other Concerns
Protection of personal information is not an isolated concern
to those with rare condition, but it is of particular relevance.
McCormack et al. (39) highlighted the concern around genetic
discrimination due to the increasing progress in genetic research,
were, although the desire for more access to clinical trials and
cures was strong, there was concern that private companies could
use the data negatively and mishandle that information. Gainotti
et al. (40) point out that regular updates on how data is being
used, and what research is achieving is valuable to the research
participants. Further, inclusion of key rare disease organizations
in governance decisions will promote a culture among the rare
disease community of receptiveness to the benefits of research.
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Theme 4: Public Awareness
Public awareness (including through wider media presence and
public health campaigns), was listed by 30% of the respondents
as one of three priorities to improve information sharing and
communication for rare disease(s) in Northern Ireland. A study
by Castillo-Esparcia and López-Villafranca (41) investigated
engagement of rare disease organizations with the public via
media coverage and although a focus on human stories raised
awareness, it did not increase knowledge of the public to specific
diseases. Another study of online communication of rare disease
organizations found that although most had websites, only a
minority used their website to communicate with the media (42).
Another study found media coverage being used as a tool to
receive medication which had been denied previously through
traditional means (43). The power of the use of the media here
is clear—it can instigate action within health boards and systems,
and within government.
Although the theme of public awareness produced fewer
published papers, given the current era and trends a review
of social media (rather than communication) and rare disease
literature would more likely bring forth research that looking at
rare disease focused public health campaigns or strategies. Such
a review would be a valuable contribution, as public awareness is
one of four overarching themes raised by our survey.
Strengths and Limitations
An important strength of this study is that it is the first
approach to gain views from a range of individuals living and
working with rare diseases in Northern Ireland. The survey itself
was developed in an iterative process by collaboration with a
national rare disease charity (NIRDP). We appreciate that the
approach promoting the survey primarily via the NIRDP may
not have reached all individuals living and working with rare
diseases in Northern Ireland, but it was selected as a pragmatic
approach incorporating reach to more than 60 partner rare
disease charities, medical professionals, patients, and carers.
Social media has been used successfully to promote other health
related surveys through charities and hospital groups [(44), p. 284
patient responses; (45), p. 155 responses]. Two hundred and forty
individuals accessed this survey with responses demonstrating a
variety of viewpoints from individuals self-selected as patients,
family members of patients, carers, healthcare professionals,
social support practitioners, policy makers etc. Of note, only 38%
of respondents accessing the survey completed it in full, which
may be partially explained by the nature of the question set; the
survey was designed to collect important information without
directing responses in free text fields, yet with as little respondent
burden as possible. It was therefore possible to skip questions and
those skipped tended to be around the question of promoting /
barriers to engagement and suggesting three priorities for change.
Further dissemination via print media and local radio may have
helped generate more respondents for future research. There is
no coordinated rare disease research infrastructure in Northern
Ireland so the creation of a network for rare diseases in Northern
Ireland, as proposed in this study, would further help improve
dissemination and responses for future research.
Another strength of this study the mixed methods approach
using an initial survey to evaluate the perceived availability
of resources and communication preferences for rare diseases
across Northern Ireland, followed by a literature review to place
these findings in an international context. We appreciate that
not everyone has access to or routinely uses the internet so the
use of a primarily online resource may limit their participation.
However, the survey was also available in hard copy and discussed
at public meetings focused on rare diseases to be as inclusive as
practically possible with available resources. Within the literature
review, a limitation is that we only included studies in English
due to the native language of the authors. We also restricted the
formal literature review search strategy to articles published from
2012–2018 as a major aim was to place current findings from the
survey within Northern Ireland in a wider context. Of note, this
includes literature published since the launch of the UK strategy
for rare disease (3) and the Northern Ireland Rare Disease
Implementation Plan (4). Further 2018 & 2019 publications have
been included to help discuss our results in the light of more
recent knowledge. Widening the online resources searched and
including other literature may have revealed further relevant
information, however this was not planned as a systematic review
and our approach does provide good coverage of the available
relevant literature. Similarly, our search strategy was limited
to the broad scope of “rare disease,” so we may have missed
developments that are specific to a particular rare disease or more
general rare disease terms.
CONCLUSIONS
Many outcomes from our information and communication
survey conducted in Northern Ireland mirror those from
international research worldwide, emphasizing that much work
remains to be conducted to improve communication around rare
diseases. This research provides a wealth of consensus evidence
that improvements to communication around rare disease are
essential to improve the quality of life of those affected by a
rare disease(s). The research also demonstrates the practical
development of priorities for improvement based on the voices
of those living and working with a rare condition.
With research recognizing the challenges faced by those
affected by a rare condition, international collaborations are
being formed that will bring significant improvements in
health and social care systems. As changes are implemented,
it is essential that further research be conducted to
evaluate effectiveness and to ensure that the best possible
structures and mechanisms are put in place to improve
communication and information systems for those affected by a
rare condition.
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